SOPHARMA AD (92/2022) Sales revenues for November 2022
Report no 92/2022
- 05.12.2022, 13:00
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
-
SOPHARMA AD (91/2022) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 2 December 2022.
Report no 91/2022- 05.12.2022, 10:07
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (90/2022) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 1 December 2022.
Report no 90/2022- 02.12.2022, 14:22
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (89/2022) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 1 December 2022.
Report no 89/2022- 02.12.2022, 14:14
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (88/2022) Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS
Report no 88/2022- 29.11.2022, 14:16
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (87/2022) Consolidated financial report according to IFRS as at 30 September 2022
Report no 87/2022- 29.11.2022, 13:24
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (86/2022) Tender offer to the shareholders of "Sopharma" AD by "Donev Investments Holding" AD
Report no 86/2022- 28.11.2022, 14:22
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (85/2022) Sales revenues for October 2022
Report no 85/2022- 07.11.2022, 13:03
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (84/2022) Individual financial report according to IFRS as at 30 September 2022
Report no 84/2022- 31.10.2022, 13:19
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (83/2022) Merger of the subsidiary "Biopharm-engineering" AD into "Sopharma" AD
Report no 83/2022- 26.10.2022, 14:02
- Kategoria: Biznes i finanse
- Źródło: ESPI
